Aichelin, K. (2017). Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma.
Chicago-Zitierstil (17. Ausg.)Aichelin, Katharina. Development of a CD22-specific Chimeric Antigen Receptor (CAR) for the Adoptive T Cell Therapy of Leukemia and Lymphoma. Heidelberg, 2017.
MLA-Zitierstil (9. Ausg.)Aichelin, Katharina. Development of a CD22-specific Chimeric Antigen Receptor (CAR) for the Adoptive T Cell Therapy of Leukemia and Lymphoma. 2017.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.